martedì 28 aprile 2009

Swine Flu and Financial Markets

Swine Flu is surely a severe world emergency causing a number of victims and infected people increasing everyday; but it is likely to be a good business. It is better not to forget it...

While we are impressed and scared just watching TV or dealing with a dish of sausages, financial markets are not wasting time. Some sectors are falling (i.e. airlines or hotel groups) but pharmaceutical companies are jumping: Tamiflu, produced by the Swiss company Roche, will be used for swine flu and this info contributed to soar the company. Similar positive trends for Glaxosmithkline, owner of Relenza (a drug used to cure influenza) and Sanofi-Aventis: both companies, operating in the sector of vaccines' production, are hoping to highly increase their respective business on the base of their mid-term capability to develop a specific vaccine.

It is true that "business is business": yet it is rather disgusting to see that there is always someone ready to make money (a lot of money), with a discrete cynicism, thanks to epidemic deseases. But this is the ethics' domain; this is not business...

That's the market! Why are you wondering?

Nessun commento: